FDA grants orphan drug designation to gene therapy for Batten disease – Healio
|
FDA grants orphan drug designation to gene therapy for Batten disease
Healio The FDA has granted orphan drug designation to an adeno-associated virus-based gene therapy for treating infantile Batten disease, according to a press release from Abeona Therapeutics. Batten disease. an extremely rare and fatal autosomal recessive … |
